The same treatment also proved to be effective in another in vivo AD model, characterized by the spreading of aggregated tau from the entorhinal cortex to the hippocampal region; in this study, the authors demonstrated that aggregated tau was phagocytosed by microglia and released in EVs. This evidence concerns the gene MAPT and Alzheimer disease.